|
|
| 基石藥業, 02616.HK - 綜合現金流量表 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
| 經營活動之現金流量 |
-612,469 |
-1,484,024 |
-508,070 |
-1,080,722 |
-791,107 |
-240,186 |
-213,006 |
| 投資回報及融資費用之現金流量 |
-2,136 |
7,450 |
21,543 |
38,915 |
5,111 |
5,754 |
44 |
| 已收利息 |
9,672 |
9,692 |
22,863 |
39,218 |
5,111 |
6,054 |
44 |
| 已付利息 |
-11,808 |
-2,242 |
-1,320 |
-303 |
0 |
-300 |
0 |
| 已收股息 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 已付股息 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 其他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 退回/(已繳)稅項 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 投資活動之現金流量 |
355,447 |
-836,244 |
1,157,869 |
-698,102 |
-382,812 |
262,246 |
-753,513 |
| 增添固定資產 |
0 |
-85,900 |
-31,628 |
-6,213 |
-7,012 |
-12,130 |
-1,101 |
| 出售固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 投資增加 |
0 |
-190,297 |
0 |
-34,065 |
-286,360 |
-3,743,048 |
-767,879 |
| 投資減少 |
69,391 |
10,125 |
8,482 |
121,795 |
664,666 |
4,017,661 |
15,390 |
| 與關聯人士之現金流量 |
0 |
0 |
0 |
0 |
-307,219 |
0 |
304,029 |
| 其他 |
286,056 |
-570,172 |
1,181,015 |
-779,619 |
-446,887 |
-237 |
-303,952 |
| 融資活動前之現金流量 |
-259,158 |
-2,312,818 |
671,342 |
-1,739,909 |
-1,168,808 |
27,814 |
-966,475 |
| 融資活動之現金流量 |
40,275 |
94,546 |
1,390,749 |
2,091,635 |
1,662,420 |
0 |
1,010,503 |
| 新增貸款 |
113,042 |
96,215 |
58,582 |
0 |
0 |
0 |
0 |
| 償還貸款 |
-75,296 |
-18,499 |
-6,961 |
-4,683 |
0 |
0 |
0 |
| 定息/債項工具融資 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 償還定息/債項工具 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 股本融資 |
2,529 |
16,830 |
1,360,928 |
2,096,318 |
1,969,639 |
0 |
706,474 |
| 與關聯人士之現金流量 |
0 |
0 |
0 |
0 |
-307,219 |
0 |
304,029 |
| 其他 |
0 |
0 |
-21,800 |
0 |
0 |
0 |
0 |
| 現金及等同現金之增加/(減少) |
-218,883 |
-2,218,272 |
2,062,091 |
351,726 |
493,612 |
27,814 |
44,028 |
| 年初之現金及現金等同項目 |
742,724 |
3,024,548 |
1,126,436 |
701,336 |
83,390 |
59,539 |
15,511 |
| 外匯兌換率變動之影響/(其他) |
34,843 |
-63,552 |
-163,979 |
73,374 |
124,334 |
-3,963 |
0 |
| 年終之現金及現金等同項目 |
558,684 |
742,724 |
3,024,548 |
1,126,436 |
701,336 |
83,390 |
59,539 |
| 貨幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
| 單位 |
| 核數師意見 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|